KOD Overview
Upcoming Projects (KOD)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (KOD)
-
A Third View: Investigating the phase 3 GLOW clinical trial of Kodiak Sciences' Tarcocimab Tedromer as a treatment for non-proliferative diabetic retinopathy.
Ticker: KOD
Executed On: Nov 21, 2023 at 11:00 AM EST -
A Second View: Investigating the phase 3 GLOW clinical trial of Kodiak Sciences' Tarcocimab Tedromer as a treatment for non-proliferative diabetic retinopathy.
Ticker: KOD
Executed On: Nov 16, 2023 at 05:00 PM EST -
Investigating the phase 3 GLOW clinical trial of Kodiak Sciences' Tarcocimab Tedromer as a treatment for non-proliferative diabetic retinopathy.
Ticker: KOD
Executed On: Nov 14, 2023 at 03:00 PM EST -
A second in depth discussion of the clinical landscape for Macular Edema, with a close look at the phase 3 results of Kodiak Sciences tarcocimab and its potential in this space.
Tickers: KOD, REGN
Executed On: Sep 08, 2022 at 08:00 AM EDT -
An in depth discussion of the clinical landscape for Macular Edema, with a close look at the phase 3 results of Kodiak Sciences tarcocimab and its potential in this space.
Tickers: KOD, REGN
Executed On: Sep 02, 2022 at 11:00 AM EDT
Upcoming & Overdue Catalysts (KOD)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (KOD)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
